Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02056912Completed
Single-arm trial, sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoints: Additional mutation in the studied candidate gene XX at 6 months, Altered lipids composition in blood red cells membranes at 6 months and 3 more. Started Jan 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02056912.